|
|
Volumn 327, Issue 5967, 2010, Pages 772-774
|
|
Replacing an immune system gone haywire
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
INSULIN;
CHEMOTHERAPY;
DISEASE TREATMENT;
IMMUNE SYSTEM;
MEDICINE;
PUBLIC HEALTH;
AUTOIMMUNE DISEASE;
AUTOTRANSPLANTATION;
BLOOD ANALYSIS;
BLOOD CELL;
BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CELL DIFFERENTIATION;
CELL PROLIFERATION;
CLINICAL ASSESSMENT;
CLINICAL TRIAL;
DIABETES MELLITUS;
DISEASE SEVERITY;
HEMATOLOGIC MALIGNANCY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HOST;
HUMAN;
IMMUNE SYSTEM;
JUVENILE RHEUMATOID ARTHRITIS;
LONG TERM CARE;
MORTALITY;
MULTIPLE SCLEROSIS;
ORGAN DONOR;
PHYSICIAN;
PRIORITY JOURNAL;
REMISSION;
RHEUMATOLOGY;
RISK FACTOR;
SCIENCE;
SCIENTIST;
SCLERODERMA;
SHORT SURVEY;
SICKLE CELL ANEMIA;
STEM CELL TRANSPLANTATION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
T LYMPHOCYTE;
IMMUNOSUPPRESSIVE TREATMENT;
NOTE;
PHYSIOLOGY;
RECURRENT DISEASE;
AUTOIMMUNE DISEASES;
CLINICAL TRIALS AS TOPIC;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNE SYSTEM;
RECURRENCE;
REMISSION INDUCTION;
TRANSPLANTATION CONDITIONING;
|
|
EID: 76749095958
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.327.5967.772 Document Type: Short Survey |
|
Times cited : (12)
|
|
References (0)
|
